JFG Life Sciences Foundation (investor - Others)

See something wrong or missing? Let us know
Offices:Basel
Average round investment:4.26M USD
Average number per year:1.0
Distribution: 2024 (1)2022 (1)
Portfolio companies: Switzerland NXI TherapeuticsSwitzerland Invasight
Mostly invests in: Switzerland Switzerland (2) Biotech (2)

2 tracked investments in:


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to JFG Life Sciences Foundation

Name Criteria
United States Rhia Ventures
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland Swiss Invest Group
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Dynamk Capital
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland UZH Life Sciences Fund
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Australia Tenmile
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland Forty51 Ventures
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland BaseLaunch
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland Zühlke Ventures AG
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Cybernetix Ventures
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Germany Springboard Health Angels
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Top